Literature DB >> 24292718

The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.

Malte Puchert1, Jürgen Engele.   

Abstract

The chemokine SDF-1/CXCL12 induces and modulates major steps of ontogenesis, regeneration and tumorigenesis. Depending on the organ or tissue, CXCL12 serves as a proliferation or cell survival factor, influences differentiation, induces adhesion and/or regulates cell migration. These functions are mediated by the two chemokine receptors, CXCR4 and CXCR7. Whereas CXCR4 is still viewed as the sole G-protein-activating and, hence, signaling receptor for CXCL12, CXCR7 is regarded as a non-classic scavenging or decoy receptor that modulates the function of CXCR4. However, this view might be too limited, since evidence has accumulated favoring a cell-type-specific mode of CXCL12 signaling. In addition to the "classic" CXCL12 signaling mode via CXCR4, CXCR4 and CXCR7 have to form a receptor unit for successful CXCL12 signaling in some cells. Moreover, examples exist whereby CXCL12 receptors split functions or switch roles, such that CXCR7 (instead of CXCR4) mediates signal transduction. The obvious lack of a universal mode of CXCL12 signaling urges a re-evaluation of the role of this chemokine in development, health and disease. This review depicts the exceptional characteristics of CXCL12-induced signal transduction in various cells and organs, points out remaining controversies and mentions consequences for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292718     DOI: 10.1007/s00441-013-1747-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  29 in total

1.  Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.

Authors:  Melinda S Hanes; Catherina L Salanga; Arnab B Chowdry; Iain Comerford; Shaun R McColl; Irina Kufareva; Tracy M Handel
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

2.  Cxcr4 is transiently expressed in both epithelial and mesenchymal compartments of nascent hair follicles but is not required for follicle formation.

Authors:  Rachel Sennett; Amélie Rezza; Katherine L Dauber; Carlos Clavel; Michael Rendl
Journal:  Exp Dermatol       Date:  2014-10       Impact factor: 3.960

3.  CXCR4 promotes GSK3β expression in pancreatic cancer cells via the Akt pathway.

Authors:  Shijie Ma; Qianjun Li; Feng Pan
Journal:  Int J Clin Oncol       Date:  2014-08-23       Impact factor: 3.402

4.  Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia.

Authors:  Xiaozhen Dai; Xiaoqing Yan; Jun Zeng; Jing Chen; Yuehui Wang; Jun Chen; Yan Li; Michelle T Barati; Kupper A Wintergerst; Kejian Pan; Matthew A Nystoriak; Daniel J Conklin; Gregg Rokosh; Paul N Epstein; Xiaokun Li; Yi Tan
Journal:  Circ Res       Date:  2017-01-30       Impact factor: 17.367

5.  Requirement of CXCL12-CXCR7 signaling for CD20(-) CD138(-) double-negative population in lymphoplasmacytic lymphoma.

Authors:  Naoki Wada; Jun-Ichiro Ikeda; Satoshi Nojima; Shin-Ichiro Tahara; Kenji Ohshima; Daisuke Okuzaki; Eiichi Morii
Journal:  Lab Invest       Date:  2016-02-15       Impact factor: 5.662

6.  CXCR7 expression disrupts endothelial cell homeostasis and causes ligand-dependent invasion.

Authors:  Jennifer E Totonchy; Lisa Clepper; Kevin G Phillips; Owen J T McCarty; Ashlee V Moses
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

7.  CXCR4 Antagonist AMD3100 Suppresses the Long-Term Abnormal Structural Changes of Newborn Neurons in the Intraventricular Kainic Acid Model of Epilepsy.

Authors:  Chengguang Song; Wangshu Xu; Xiaoqian Zhang; Shang Wang; Gang Zhu; Ting Xiao; Mei Zhao; Chuansheng Zhao
Journal:  Mol Neurobiol       Date:  2015-02-04       Impact factor: 5.590

Review 8.  Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.

Authors:  Vincent Duval; Paul Alayrac; Jean-Sébastien Silvestre; Angélique Levoye
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

Review 9.  The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.

Authors:  Yonatan Ganor; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-03-02       Impact factor: 3.575

10.  EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma.

Authors:  Ji Yun Lee; Joo Hyun Kim; Heejin Bang; Junhun Cho; Young Hyeh Ko; Seok Jin Kim; Won Seog Kim
Journal:  Sci Rep       Date:  2021-05-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.